VEGFA and non-small cell lung carcinoma: On this matter, some studies explained how raising levels of VEGF in COPD patients with NSCLC resulted in higher circulating levels of monocytic MDSCs (M-MDSCs) and lower levels of granulocytic MDSCs (G-MDSCs), leading to increased survival of NSCLC patients [90].